首页> 美国卫生研究院文献>Liver Cancer >Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis

【2h】

Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis

机译：索拉非尼：体验和更好的副作用管理改善肝细胞癌患者的整体生存：真实的回顾性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Sorafenib is the first-line treatment for advanced hepatocellular carcinoma (HCC). The management of its side effects is improving. This study aimed to assess, in real life, if this translates into a better prognosis.

机译：Sorafenib是先进肝细胞癌（HCC）的一线治疗方法。其副作用的管理正在改善。本研究旨在在现实生活中评估，如果这意味着更好的预后。

著录项

期刊名称 Liver Cancer
作者
Jean-Luc Raoul; Xavier Adhoute; Guillaume Penaranda; Hervé Perrier; Paul Castellani; Valérie Oules; Marc Bourlière;
展开▼
作者单位

展开▼
年(卷),期 2019(8),6
年度 2019
页码 457–467
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

机译：Sorafenib;肝细胞癌;学习曲线;预后;不良事件;

相似文献

外文文献
中文文献
专利

1. Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis [J] . Raoul Jean-Luc, Adhoute Xavier, Penaranda Guillaume, Liver cancer. . 2019,第6期

机译：索拉菲尼布：体验和更好的副作用管理改善肝细胞癌患者的整体生存：真实的回顾性分析
2. Development of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib: a systematic-review and meta-analysis of the impact on survival [J] . Abdel-Rahman Omar, Lamarca Angela Expert review of gastroenterology & hepatology . 2017,第1a6期

机译：索拉非尼治疗晚期肝细胞癌患者的索拉非尼相关副作用的发展：系统审查和荟萃分析对生存的影响
3. Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience [J] . Assaf Moore, Michal Cohen-Naftaly, Ofer Benjaminov, Journal of Cancer . 2016,第8期

机译：放射疗法和索拉非尼在肝细胞癌患者管理中的优势在于提高生存率：单中心经验
4. In-depth Proteomic Analysis of Sorafenib-induced Resistance in Hepatocellular Carcinoma Using High Resolution LC-MS/MS [C] . Junho Park, Dohyun Han, Su Jong Yu, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：高分辨率LC-MS / MS的肝细胞癌中索拉非尼诱导抗性的深入蛋白质组学分析
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. A real-life experience of sorafenib treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis at Cathay General Hospital 2007–2015 [O] . Chi-Chun Huang, Hsin-Yi Chen, Ruei-Hsin Chang, 2019

机译：索拉非尼治疗晚期肝细胞癌的真实经验：国泰综合医院的回顾性分析2007-2015年
7. Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience [O] . Assaf Moore, Michal Cohen-Naftaly, Ofer Benjaminov, 2016

机译：放射疗法和索拉非尼在管理肝细胞癌患者中导致了提高生存：单一中心经验

Sorafenib: Experience and Better Manage­ment of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅

Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis